Cynthia Forlini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cynthia Forlini has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Eric Racine
Institut de recherches cliniques de Montréal
16 shared publications - Wayne Hall
National Centre for Youth Substance Use Research, School of Psychology The University of Queensland St Lucia Queensland Australia
11 shared publications - Adrian Carter
School of Psychological Sciences, Monash University, Melbourne, Australia
9 shared publications Eric Racine
Institut de recherches cliniques de Montréal
4 shared publications- Jayne Lucke
Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Australia
4 shared publications - Charmaine Jensen
The University of Queensland Centre for Youth Substance Abuse Research, St Lucia, Brisbane, QLD, Australia
3 shared publications
Latest Publications
- 3 July 2023
- Published by Taylor & Francis in AJOB Neuroscience
- Vol. 14 (3) , 279-282
Certainty, Science, and the Brain-Based Definition of Death
- 3 July 2023
- Published by Taylor & Francis in AJOB Neuroscience
- Vol. 14 (3) , 279-282
Certainty, Science, and the Brain-Based Definition of Death
- 3 April 2023
- Published by Taylor & Francis in AJOB Neuroscience
- Vol. 14 (2) , 131-134
Psychedelic Research for Dementia Risks Perpetuating Structural Failures and Inadequacies in Aged Care
Peterson et al. (2023) outline a broad ethics agenda for imminent research on psychedelic agents for Alzheimer’s disease and related dementias (AD/ADRD) by acknowledging the therapeutic promise of ...
- 3 April 2023
- Published by Taylor & Francis in AJOB Neuroscience
- Vol. 14 (2) , 131-134
Psychedelic Research for Dementia Risks Perpetuating Structural Failures and Inadequacies in Aged Care
Peterson et al. (2023) outline a broad ethics agenda for imminent research on psychedelic agents for Alzheimer’s disease and related dementias (AD/ADRD) by acknowledging the therapeutic promise of ...
- 1 October 2020
- Published by Taylor & Francis in AJOB Neuroscience
- Vol. 11 (4) , 240-242
Empirical Data Is Failing to Break the Ethics Stalemate in the Cognitive Enhancement Debate
- 1 October 2020
- Published by Taylor & Francis in AJOB Neuroscience
- Vol. 11 (4) , 240-242
Empirical Data Is Failing to Break the Ethics Stalemate in the Cognitive Enhancement Debate
- 1 November 2019
- Published by Elsevier in International Journal of Drug Policy
- Vol. 73, 58-63
Seeking legitimacy for broad understandings of substance use
- 1 November 2019
- Published by Elsevier in International Journal of Drug Policy
- Vol. 73, 58-63
Seeking legitimacy for broad understandings of substance use
- 2 October 2019
- Published by Taylor & Francis in AJOB Neuroscience
- Vol. 10 (4) , 178-180
Beyond Flourishing: Intersecting Uses and Interests in the Neurotechnology Marketplace
(2019). Beyond Flourishing: Intersecting Uses and Interests in the Neurotechnology Marketplace. AJOB Neuroscience: Vol. 10, No. 4, pp. 178-180.
- 2 October 2019
- Published by Taylor & Francis in AJOB Neuroscience
- Vol. 10 (4) , 178-180
Beyond Flourishing: Intersecting Uses and Interests in the Neurotechnology Marketplace
(2019). Beyond Flourishing: Intersecting Uses and Interests in the Neurotechnology Marketplace. AJOB Neuroscience: Vol. 10, No. 4, pp. 178-180.
- Open Access
- 19 November 2018
- Published by Springer Nature in BMC Public Health
- Vol. 18 (1) , 1270
Non-medical prescription stimulant use to improve academic performance among Australian university students: prevalence and correlates of use
Some university students consume pharmaceutical stimulants without a medical prescription with the goal of improving their academic performance. The prevalence of this practice has been well documented in the US, but less so in other countries. The potential harms of using prescription stimulants require a better understanding of the prevalence of this practice within Australian universities. An internet survey of 1136 Australian students was conducted in 2015 in three large Australian universities. Students were asked about their personal use of prescription stimulants, attitudes and experiences with prescription stimulants. They were also asked about their use of caffeine, energy drinks and illicit drugs to enhance their academic performance. Lifetime self-reported use of stimulant medication to improve academic performance was 6.5, and 4.4% in the past year. Students were far more likely to report using coffee and energy drinks (41.4 and 23.6% respectively, lifetime use) than prescription stimulants to help them study and complete university assessments. Non-medical use of prescription stimulants was strongly associated with a history of illicit drug use. The prevalence of nonmedical prescription stimulant use to improve academic performance is low among university students in Australia, especially when compared with their use of coffee and energy drinks.
- 19 November 2018
- Published by Springer Nature in BMC Public Health
- Vol. 18 (1) , 1270
Open AccessNon-medical prescription stimulant use to improve academic performance among Australian university students: prevalence and correlates of use
Some university students consume pharmaceutical stimulants without a medical prescription with the goal of improving their academic performance. The prevalence of this practice has been well documented in the US, but less so in other countries. The potential harms of using prescription stimulants require a better understanding of the prevalence of this practice within Australian universities. An internet survey of 1136 Australian students was conducted in 2015 in three large Australian universities. Students were asked about their personal use of prescription stimulants, attitudes and experiences with prescription stimulants. They were also asked about their use of caffeine, energy drinks and illicit drugs to enhance their academic performance. Lifetime self-reported use of stimulant medication to improve academic performance was 6.5, and 4.4% in the past year. Students were far more likely to report using coffee and energy drinks (41.4 and 23.6% respectively, lifetime use) than prescription stimulants to help them study and complete university assessments. Non-medical use of prescription stimulants was strongly associated with a history of illicit drug use. The prevalence of nonmedical prescription stimulant use to improve academic performance is low among university students in Australia, especially when compared with their use of coffee and energy drinks.
- 2 September 2018
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 18 (9) , 58-60
Surveillance Medicine in the DigitalEra: Lessons From Addiction Treatment
- 2 September 2018
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 18 (9) , 58-60
Surveillance Medicine in the DigitalEra: Lessons From Addiction Treatment
- 5 June 2018
- Published by Oxford University Press (OUP) in Public Health Ethics
- Vol. 11 (2) , 121-125
Public Mental Health Ethics: Helping Improve Mental Health for Individuals and Communities
- 5 June 2018
- Published by Oxford University Press (OUP) in Public Health Ethics
- Vol. 11 (2) , 121-125
Public Mental Health Ethics: Helping Improve Mental Health for Individuals and Communities
A prospectus for ethical analysis of ageing individuals' responsibility to prevent cognitive decline
As the world's population ages, governments and non‐governmental organizations in developed countries are promoting healthy cognitive ageing to reduce the rate of age‐related cognitive decline and sustain economic productivity in an ageing workforce. Recommendations from the Productivity Commission (Australia), Dementia Australia, Government Office for Science (UK), Presidential Commission for the Study of Bioethical Issues (USA), Institute of Medicine (USA), among others, are encouraging older adults to engage in mental, physical, and social activities. These lifestyle recommendations for healthy cognitive ageing are timely and well supported by scientific evidence but they make implicit normative judgments about the responsibility of ageing individuals to prevent cognitive decline. Ethical tensions arise when this individual responsibility collides with social and personal realities of ageing populations. First, we contextualize the priority given to healthy cognitive ageing within the current brain‐based medical and social discourses. Second, we explore the individual responsibility by examining the economic considerations, medical evidence and individual interests that relate to the priority given to healthy cognitive ageing. Third, we identify three key ethical challenges for policymakers seeking to implement lifestyle recommendations as an effective population‐level approach to healthy cognitive ageing. The result is a prospectus for future in‐depth analysis of ethical tensions that arise from current policy discussions of healthy cognitive ageing.
A prospectus for ethical analysis of ageing individuals' responsibility to prevent cognitive decline
As the world's population ages, governments and non‐governmental organizations in developed countries are promoting healthy cognitive ageing to reduce the rate of age‐related cognitive decline and sustain economic productivity in an ageing workforce. Recommendations from the Productivity Commission (Australia), Dementia Australia, Government Office for Science (UK), Presidential Commission for the Study of Bioethical Issues (USA), Institute of Medicine (USA), among others, are encouraging older adults to engage in mental, physical, and social activities. These lifestyle recommendations for healthy cognitive ageing are timely and well supported by scientific evidence but they make implicit normative judgments about the responsibility of ageing individuals to prevent cognitive decline. Ethical tensions arise when this individual responsibility collides with social and personal realities of ageing populations. First, we contextualize the priority given to healthy cognitive ageing within the current brain‐based medical and social discourses. Second, we explore the individual responsibility by examining the economic considerations, medical evidence and individual interests that relate to the priority given to healthy cognitive ageing. Third, we identify three key ethical challenges for policymakers seeking to implement lifestyle recommendations as an effective population‐level approach to healthy cognitive ageing. The result is a prospectus for future in‐depth analysis of ethical tensions that arise from current policy discussions of healthy cognitive ageing.
- Open Access
- 2 October 2017
- Published by Taylor & Francis in AJOB Neuroscience
- Vol. 8 (4) , W1-W2
Throwing the Ethics (Hand)Book at Professional Organizations in the Neurological Sciences
(2017). Throwing the Ethics (Hand)Book at Professional Organizations in the Neurological Sciences. AJOB Neuroscience: Vol. 8, No. 4, pp. W1-W2.
- 2 October 2017
- Published by Taylor & Francis in AJOB Neuroscience
- Vol. 8 (4) , W1-W2
Open AccessThrowing the Ethics (Hand)Book at Professional Organizations in the Neurological Sciences
(2017). Throwing the Ethics (Hand)Book at Professional Organizations in the Neurological Sciences. AJOB Neuroscience: Vol. 8, No. 4, pp. W1-W2.